Risk factors for periorbital dermatitis in patients using dorzolamide/timolol eye drops

Risk factors for periorbital dermatitis in patients using dorzolamide/timolol eye drops

Abstract This study assessed the clinical risk factors for periorbital dermatitis (PD) after using dorzolamide/timolol eye drops in a total of 1282 glaucoma patients. Both the PD(+) group and the PD(−) group were evaluated using clinical data such as age, sex, dosing duration, presence of benzalkoni...

Full description

Bibliographic Details
Main Authors:	Myungjin Kim, Hyoju Jang, Seungsoo Rho
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-09-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-97565-0

Similar Items

Quality of dorzolamide hydrochloride and timolol maleate containing eye drops distributed online
by: Sára Merczel, et al.
Published: (2023-06-01)

Comparative study to assess efficacy and safety of brinzolamide1% and timolol0.5% fixed combination eye drops versus dorzolamide2% and timolol0.5% fixed combination eye drops in management of open-angle glaucoma
by: Prerana Agarwal, et al.
Published: (2022-01-01)

A study of effectiveness and adherence between fixed combination dorzolamide /timolol maleate and non-fixed dorzolamide and timolol xe in open angle glaucoma
by: Rasid, Noor Khairul
Published: (2015)

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
by: Miguel A Teus, et al.
Published: (2009-11-01)

Brinzolamide/timolol versus dorzolamide/timolol fixed combinations: A hospital-based, prospective, randomized study
by: Mary S Galose, et al.
Published: (2016-01-01)

Antioxidant activity of dorzolamide/timolol fixed combination in neuroprotective therapy in glaucoma
by: N. I. Kurysheva, et al.
Published: (2014-07-01)

Effects of dorzolamide/timolol fixed combination on retrobulbar hemodynamics in pseudoexfoliative glaucoma
by: Mustafa Eliacik, et al.
Published: (2016-01-01)

Antioxidant activity of dorzolamide/timolol fixed combination in neuroprotective therapy in glaucoma
by: N. I. Kurysheva, et al.
Published: (2014-07-01)

Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma.
by: Katrin Lorenz, et al.
Published: (2017-01-01)

Comparison of the efficacy and safety of fixed combination travoprost/timolol and dorzolamide/timolol in patients with primary open-angle glaucoma and ocular hypertension
by: Babić Nikola, et al.
Published: (2013-01-01)

Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/ timolol among patients with open-angle glaucoma or ocular hypertension
by: Sanseau A, et al.
Published: (2013-02-01)

Effects of dorzolamide/timolol and tafluprost on intraocular pressure and pupil diameter in healthy dogs
by: Nathalie Moro Bassil Dower, et al.

Efficacy of adjuvant topical timolol–dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study
by: Ahmad Mirshahi, et al.
Published: (2019-06-01)

Efficacy and tolerability of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure: a meta-analysis of randomized controlled trials.
by: Miao He, et al.
Published: (2013-01-01)

Pharmacodynamic equivalence study of two preparations of eye drops, containing dorzolamide in healthy volunteers
by: Gatchev Emil M., et al.
Published: (2016-01-01)

Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination
by: Contreras-Salinas H, et al.
Published: (2021-02-01)

Patient perspectives when switching from Cosopt&reg; (dorzolamide-timolol) to Azarga&trade; (brinzolamide-timolol) for glaucoma requiring multiple drug therapy
by: Auger GA, et al.
Published: (2012-12-01)

Effectiveness and safety of hypotensive therapy of primary glaucoma with a Russian generic fixed combination of dorzolamide and timolol
by: S. Yu. Petrov, et al.
Published: (2022-09-01)

Effect of dorzolamide-timolol fixed combination prophylaxis on intraocular pressure spikes after intravitreal bevacizumab injection
by: Sehnaz Ozcaliskan, et al.
Published: (2015-06-01)

Rational use of the fixed combination of dorzolamide &ndash; timolol in the management of raised intraocular pressure and glaucoma
by: Jason Yeh, et al.
Published: (2008-06-01)

Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination [Erratum]
by: Contreras-Salinas H, et al.
Published: (2022-02-01)

NIGHTMARES FROM TOPICAL TIMOLOL EYE DROPS: A CASE REPORT
by: Yousaf Jamal Mahsood, et al.
Published: (2020-09-01)

The treatment of refractory periorbital dermatitis
by: Elana A Meer, et al.
Published: (2023-01-01)

Effects of timolol maleate eye drops on experimentally dilated cardiomyopathy and healthy rabbits
by: Mitsuhiro Isaka, et al.
Published: (2021-08-01)

Preparation and testing of buffered eye drops containing pilocarpine chloride with timolol maleate
by: Rakić Danijela, et al.
Published: (2006-01-01)

Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog
by: Shimizu Y, et al.
Published: (2015-03-01)

Effects of Latanoprost 0.005%/Timolol Maleate 0.5% and Dorzolamide 2%/Timolol Maleate 0.5% Fixed Combinations on 24-hour Intraocular Pressure in Patients with Primary Open-Angle Glaucoma
by: Berna Yüce, et al.
Published: (2012-01-01)

Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension
by: Nicholas P Bell, et al.
Published: (2010-11-01)

Additive intraocular pressure-lowering effect of dorzolamide 1%/timolol 0.5% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma
by: Mizoguchi T, et al.
Published: (2011-10-01)

Allergic contact dermatitis to eye drops
by: Yasmeen Jabeen Bhat, et al.
Published: (2015-01-01)

Selective laser trabeculoplasty versus 0·5% timolol eye drops in the management of glaucoma in Tanzania
by: Olusola Olawoye, et al.
Published: (2021-11-01)

Intraocular pressure reduction of fixed combination timolol maleate 0.5% and dorzolamide 2% (Cosopt) administered three times a day
by: Moisseiev E,&nbsp;Lazar M, et al.
Published: (2012-02-01)

Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension
by: Baiza-Dur&aacute;n LM, et al.
Published: (2012-07-01)

Panitumumab-Induced Periorbital Dermatitis: A Case Report
by: Pongbangpho N, et al.
Published: (2024-04-01)

Clinical study of Fuming tablet combined with Timolol Maleate eye drops in the treatment of open angle glaucoma
by: Jin Li, et al.
Published: (2019-10-01)

Five-Year Outcomes of Single Trabecular Microbypass Stent (iStent®) Implantation with Phacoemulsification in Korean Patients
by: Myungjin Kim, et al.
Published: (2023-10-01)

Whiter and Greener RP-HPLC Method for Simultaneous Determination of Dorzolamide, Brinzolamide, and Timolol Using Isopropanol as a Sustainable Organic Solvent in the Mobile Phase
by: Sami El Deeb, et al.
Published: (2024-03-01)

Green HPLC method with time programming for the determination of the co-formulated eye drops of tafluprost and timolol in their challengeable ratio
by: Walaa Nabil Abd-AlGhafar, et al.
Published: (2022-04-01)

Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops
by: Rosin LM, et al.
Published: (2013-10-01)

Comparison of the Effects of Dorzolamide/Timolol Fixed Combination versus Latanoprost on Intraocular Pressure and Ocular Perfusion Pressure in Patients with Normal-Tension Glaucoma: A Randomized, Crossover Clinical Trial.
by: Na Young Lee, et al.
Published: (2016-01-01)